NovoCure (NVCR) Shares Outstanding (Diluted) (2018 - 2026)
NovoCure (NVCR) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.97 Bn | 176.68 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Dexcom | 28.44 Bn | 27.32 Bn | 750.30 Mn | 393.60 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 457.00 Mn |
| 8 | Smith & Nephew | 27.00 Bn | 26.42 Bn | - | 873.00 Mn |
| 9 | Koninklijke Philips | 25.84 Bn | 22.71 Bn | 2.07 Bn | 968.53 Mn |
| 10 | NovoCure | 2.01 Bn | 1.57 Bn | 142.48 Mn | 116.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.01 Mn |
| Mar 31, 2026 | 114.15 Mn |
| Dec 31, 2025 | 111.47 Mn |
| Sep 30, 2025 | 111.91 Mn |
| Jun 30, 2025 | 111.57 Mn |
| Mar 31, 2025 | 110.28 Mn |
| Dec 31, 2024 | 107.83 Mn |
| Sep 30, 2024 | 108.25 Mn |
| Jun 30, 2024 | 107.70 Mn |
| Mar 31, 2024 | 107.27 Mn |
| Dec 31, 2023 | 106.39 Mn |
| Sep 30, 2023 | 106.77 Mn |
| Jun 30, 2023 | 106.29 Mn |
| Mar 31, 2023 | 105.67 Mn |
| Dec 31, 2022 | 104.66 Mn |
| Sep 30, 2022 | 104.88 Mn |
| Jun 30, 2022 | 104.63 Mn |
| Mar 31, 2022 | 104.19 Mn |
| Dec 31, 2021 | 103.43 Mn |
| Sep 30, 2021 | 103.73 Mn |